doi.org/10.1016/s2213-2600(19)30251-6

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

..., Mark Hatherill
62
The Lancet Respiratory Medicine32.80
Volume: 7, Issue: 9, Pages: 757 - 770
Published: Aug 12, 2019
Paper Fields
Paper Details
Title
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
DOI
doi.org/10.1016/s2213-2600(19)30251-6
Published Date
Aug 12, 2019
Journal
The Lancet Respiratory Medicine
Volume
7
Issue
9
Pages
757 - 770
© 2025 Pluto Labs All rights reserved.